Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-02

FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC. This action pertains to the regulatory status of the product un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRAID (sacrosidase)

Snippet

SUPPL AP for SUCRAID (SACROSIDASE)